SCHEMBL9845849

SCHEMBL9845849

[Cu]=[Cu]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5678527 0.71
Fluoride Ion SCHEMBL2004927 0.50
SCHEMBL6511984 0.50
SCHEMBL1008654 0.50
Bromide SCHEMBL9785296 0.50
Water SCHEMBL28189030 0.50
SCHEMBL25235918 0.41
SCHEMBL136790 0.41
Water SCHEMBL25437472 0.00
SCHEMBL23462224 0.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1294519-A Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient INPHARMA SA (CH) 2001-05-09 CN claimed
CN-1178699-C Pharmaceutical Compsns. contg. compounds with activity for enhancement of absorption of active ingredients 2004-12-08 CN disclosed
CN-1294519-A Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient INPHARMA SA (CH) 2001-05-09 CN disclosed
CN-1240479-A Truncated soluble tumor necrosis factor type-I and type-II receptors AMGEN INC (US) 2000-01-05 CN disclosed
EP-0450398-A2 Chondroitin sulfate complexes having anti-inflammatory activity, processes for the preparation thereof and pharmaceutical compositions containing them BIOINDUSTRIA FARMACEUTICI S.p.A. (IT) 1991-10-09 EP disclosed